openPR Logo
Press release

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

03-03-2021 01:42 PM CET | Health & Medicine

Press release from: Roots Analysis

The targeted protein degradation market is projected to grow

The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon enter the market.

To order this 330+ page report, which features 130+ figures and 145+ tables, please visit this link - https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html

The USD 3.6 billion (by 2030) financial opportunity within the target protein degradation market has been analyzed across the following segments:
Type of payment of licensing agreements
Upfront payments
Milestone payments

Type of protein degrader
Degronimids
PROTACs
SARDs / SERDs
Specific BET and DUB inhibitors
Other protein degraders

Therapeutic area
Neurodegenerative disorders
Oncological disorders
Other therapeutic areas

Route of administration
Oral
Intravenous
Other routes

Key geographical region
North America
Europe
Asia-Pacific

The Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030 report features the following companies, which we identified to be key players in this domain:
Arvinas
Captor Therapeutics
Celgene
Genetech
Kymera Therapeutics
Mission Therapeutics
Progenra
Radius Health
Sanofi Genzyme
Zenopharm

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Company Profiles

6. Clinical Trial Analysis

7. KOL Analysis

8. Publication Analysis

9. Funding and Investment Analysis

10. Partnerships and Collaborations

11. Market Sizing and Opportunity Analysis

12. Executive Insights

13. Concluding Remarks

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030 here

News-ID: 2251517 • Views:

More Releases from Roots Analysis

Digitalization Revolutionizes Biomanufacturing: Advanced Platforms Drive Operational Excellence, Visibility, and Control Across Bioprocessing Operations
Digitalization Revolutionizes Biomanufacturing: Advanced Platforms Drive Operati …
Recognizing the potential of digitalization, biomanufacturers are increasingly adopting advanced platforms that enable operational excellence, enhance visibility, improve control, and synchronization across their bioprocessing operations Biomanufacturing refers to a standardized process that utilizes microorganisms and other biological systems to produce and develop biomolecules as therapeutic modalities. Traditionally, the biopharmaceutical companies have hesitated to adopt cutting-edge digital technologies, such as cloud computing, artificial intelligence (AI), machine learning and internet of things (IoT),
Isolator based Aseptic Filling Machine Market CAGR To Exceed 8.4% by 2035, Due To The Growing Demand For Injectable Drugs | Roots Analysis
Isolator based Aseptic Filling Machine Market CAGR To Exceed 8.4% by 2035, Due T …
According to our latest market report "Isolator based Aseptic Filling Machine by Type of Compatible Primary Container, Scale of Operation, System Throughput, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the global aseptic filling machine market size, valued at USD 1,365 million in 2024, is projected to reach USD 1,531 million in 2025 and USD 3,432 million by 2035, representing a CAGR of 8.4% during the
PFAS Testing Market CAGR To Reach 11.1% by 2040, Due to the Increasing Awareness and Development of Innovative Technological Solutions | Roots Analysis
PFAS Testing Market CAGR To Reach 11.1% by 2040, Due to the Increasing Awareness …
According to our latest market report "PFAS Testing Market, till 2040 by Type Of Sample Tested, Type Of Testing Service Offered, Type of PFAS Analyte Tested, Method / Testing Standard, Type Of Technology, End-User, Geographical Regions: Industry Trends and Global Forecasts, 2022-2040", the global PFAS testing market size is projected to reach USD 1209.5 million by 2040 from USD 249.1 million in 2025, growing at a CAGR of 14.4% in
Proteomics Market CAGR To Be 7.9% % by 2035, Due To The Growing Adoption of Proteomics Solutions| Roots Analysis
Proteomics Market CAGR To Be 7.9% % by 2035, Due To The Growing Adoption of Prot …
According to our latest market report "Proteomics Market" by Type of Offering, Type of Instrument / Technology, Type of Reagent, Type of Proteomics Service, Application Area, End-users, Type of Operation and Geography: Industry Trends and Global Forecasts, Till 2035", the global protein expression market, valued at USD 2.7 billion in 2024, is estimated to reach USD 3.0 billion in 2025 and USD 6.3 billion by 2035, representing a CAGR of

All 5 Releases


More Releases for Therapeutic

Exosome Therapeutic Market : Detailed Overview
Introduction: The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028. Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market. Browse 147 Market Data Tables and 115
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The